样式: 排序: IF: - GO 导出 标记为已读
-
Heart failure home monitoring: Are we monitoring the patient or the disease? Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2024-02-20 Francesco Bianco, Valentina Bucciarelli, Francesca Santolla
-
Multimodality imaging for the global evaluation of aortic stenosis: The valve, the ventricle, the afterload Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2024-02-20 Vasileios Anastasiou, Stylianos Daios, Theodoros Karamitsos, Emmanouela Peteinidou, Matthaios Didagelos, George Giannakoulas, Constantina Aggeli, Konstantinos Tsioufis, Antonios Ziakas, Vasileios Kamperidis
Aortic stenosis (AS) is the most common valvular heart disease growing in parallel to the increment of life expectancy. Besides the valve, the degenerative process affects the aorta, impairing its elastic properties and leading to increased systemic resistance. The composite of valvular and systemic afterload mediates ventricular damage. The first step of a thorough evaluation of AS should include
-
-
Exercise and the risk of atrial fibrillation at both ends of the pathological and physiological hypertrophy spectrum Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2024-02-08 Brad Dieter
-
Oral Anticoagulation for hemodialysis patients with atrial fibrillation: the therapeutic conundrum remains. Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2024-01-26 John D Horowitz, Natasha M Rogers
Abstract not available
-
Uncomplicated Type B Aortic Dissections - Optimizing a Window of Opportunity for Endovascular Intervention Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2024-01-20 Micahel A. Coady, David H. Hsi
Abstract not available
-
Infective Endocarditis: Five Key Developments Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2024-01-20 Mark T. Mills, Peter Calvert, Gregory Y.H. Lip
Abstract not available
-
Ventricular arrhythmias in Severe Cardiac Failure – what is the role of radiotherapy? Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2024-01-15 Justin FRCP
Abstract not available
-
THE ENIGMA OF THE LEFT ATRIAL SEPTAL POUCH Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2024-01-13 Jennifer Xu, Jin K. Kim, Mark Fisher
Abstract not available
-
Effects of different exercise methods and intensities on the incidence and prognosis of atrial fibrillation Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2024-01-11 Yurong Wang, Ying Wang, Danyan Xu
Atrial fibrillation (AF), the most common sustained arrhythmia in clinical practice, exhibits a higher risk of cardiovascular adverse events. Exercise plays a crucial role in AF prevention, but the effects of different exercise types and doses are inconclusive. This review aims to comprehensively explore the most recent evidence and possible mechanisms of diverse exercise modalities concerning AF incidence
-
-
Update on the Epidemiology, Diagnosis, and Management of Infective Endocarditis: A Review Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2024-01-08 Huanhuan Miao, Yuhui Zhang, Yuqing Zhang, Jian Zhang
Despite advancements in the diagnosis and treatment of infective endocarditis (IE), the burden of IE has remained relatively high over the past decade. With an ageing population and an increasing proportion of healthcare-associated IE, the epidemiology of IE has undergone significant changes. Staphylococcus aureus has evolved as the most common causative microorganism, even in most low- and middle-income
-
One-Year Mortality and Causes of Death after Stereotactic Radiation Therapy for Refractory Ventricular Arrhythmias: A Systematic Review and Pooled Analysis Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2024-01-07 Karim Benali, Paul C. Zei, Michael Lloyd, Josef Kautzner, Charles Guenancia, Sandro Ninni, Louis Rigal, Antoine Simon, Julien Bellec, Konstantinos Vlachos, Frederic Sacher, Nefissa Hammache, Jean-Marc Sellal, Renaud de Crevoisier, Antoine Da Costa, Raphael Martins
Patients treated with cardiac stereotactic body radiation therapy (radioablation) for refractory ventricular arrhythmias are patients with advanced structural heart disease and significant comorbidities. However, data regarding 1-year mortality after the procedure are scarce. This systematic review and pooled analysis aimed at determining 1-year mortality after cardiac radioablation for refractory
-
Beyond Coronary Anatomy in Acute Myocardial Infarction: Could Stress Hyperglycemia Ratio be a new prognostic index and therapeutic target? Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-12-28 Matteo Armillotta, Luca Bergamaschi, Pasquale Paolisso, Carmine Pizzi
Abstract not available
-
Atrial septal pouches and ridges: morphological features and potential implications in clinical practice Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-12-27 Riccardo Scagliola, Domenico Caponi, Marco Scaglione
Incomplete or irregular fusion of the interatrial septum may result in several anatomic variants, including atrial septal pouches and ridges, whose knowledge and recognition are still poorly widespread in clinical practice. An educational review focused on the definition, clinical significance and diagnostic work-up of these anatomic findings was performed using PubMed, MEDLINE, Embase and Cochrane
-
Thoracic Endovascular Aortic Repair for Hyperacute, Acute, Subacute and Chronic Type B Aortic Dissection: Meta-Analysis of Reconstructed Time-to-Event Data Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-12-23 Michel Pompeu Sá, Xander Jacquemyn, James A. Brown, Danial Ahmad, Derek Serna-Gallegos, George J. Arnaoutakis, Michael J. Singh, Ibrahim Sultan
-
Revisiting Time-Restricted-Eating Interventions for Cardiometabolic Risk Reduction: Do they Have a Clinically Relevant Role? Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-12-20 Ioannis Akoumianakis
Abstract not available
-
Benefits of remote hemodynamic monitoring in heart failure Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-12-16 P.R.D. Clephas, R.A. de Boer, J.J. Brugts
Despite treatment advancements, HF mortality remains high, prompting interest in reducing HF-related hospitalizations through remote monitoring. These advances are necessary considering the rapidly rising prevalence and incidence of HF worldwide, presenting a burden on hospital resources. While traditional approaches have failed in predicting impending HF-related hospitalizations, remote hemodynamic
-
Highlighting Important (Sel ected) Issues in Hypertension Therapeutics Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-12-12 John M. Flack, Stephanie Bitner, Michael Buhnerkempe
Abstract not available
-
PFO Device Closure: Knot or Not? Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-12-09 Guy Reeder, Joerg Herrmann
Abstract not available
-
Ablation and Appendage Occlusion for Atrial Fibrillation: Does it Take Two to Tango? Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-12-02 Xaviar M. Jones, Eugenio Cingolani
Abstract not available
-
Use of Direct Oral Anticoagulants in Patients on Chronic Hemodialysis: Contemporary Appraisal on the Role for Patients with Atrial Fibrillation Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-12-01 Philipp Niehues, Julian Wolfes, Felix K. Wegner, Christian Ellermann, Benjamin Rath, Lars Eckardt
-
Prognostic value of stress hyperglycemia ratio in patients with acute myocardial infarction: a systematic review with Bayesian and frequentist meta-analysis Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-11-30 Paschalis Karakasis, Nikolaos Stalikas, Dimitrios Patoulias, Konstantinos Pamporis, Efstratios Karagiannidis, Marios Sagris, Panagiotis Stachteas, Konstantinos I. Bougioukas, Vasileios Anastasiou, Stylianos Daios, Fani Apostolidou-Kiouti, George Giannakoulas, Vassilios Vassilikos, Nikolaos Fragakis, George Giannopoulos
The present systematic review and meta-analysis aimed to investigate the prognostic value of stress hyperglycemia ratio (SHR) in patients with acute myocardial infarction (AMI). A total of 26 cohort studies, involving 87974 patients, were analyzed. The frequentist meta-analysis showed that AMI patients with SHR in the upper quantile had a significantly higher hazard of major adverse cardiovascular
-
Commentary for Gender and Race-Related Disparities in the Management of Ventricular Arrhythmias Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-11-28 Asad Khan, Henry D. Huang
Abstract not available
-
Concurrent percutaneous left atrial appendage occlusion and catheter ablation for atrial fibrillation: State-of-the-art review Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-11-21 Mark T. Mills, Peter Calvert, Periaswamy Velavan, Gregory Y.H. Lip, Dhiraj Gupta
Stroke prevention and symptom control are two integral pillars in atrial fibrillation (AF) management. Percutaneous left atrial appendage occlusion (LAAO) is effective at reducing stroke risk in high-risk patients with AF who cannot tolerate oral anticoagulant therapy, whilst catheter ablation is effective at reducing AF burden and improving quality-of-life in patients who remain symptomatic despite
-
-
Selected Highlights in the Updated Treatment of Hypertension Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-11-21 Daniel Creegan, John W. McEvoy
Hypertension remains the leading international risk factor for cardiovascular disease and premature death but, despite effective treatments, hypertension remains significantly underdiagnosed and undertreated. In the present review paper, we provide a selected update on recent developments of interest in the management of hypertension. We focus on summarizing four topics that we believe are worth highlighting
-
Extending the Success of Transcatheter Valvular Interventions to Transplanted Hearts Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-11-20 Joshua A. Rezkalla, Mackram F. Eleid
Abstract not available
-
Transcatheter valvular interventions after heart transplantation: a systematic review Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-11-10 Besart Cuko, Massimo Baudo, Olivier Busuttil, Saud Taymoor, Karine Nubret, Stephane Lafitte, Antoine Beurton, Alexandre Ouattara, Carlo De Vincentiis, Louis Labrousse, Mathieu Pernot, Lionel Leroux, Thomas Modine
An increasing number of patients experience late valvular disease after heart transplantation (HTx). While mostly being primarily addressed through surgical interventions, transcatheter valve procedures to treat these conditions are rising, particularly for unsuitable surgical candidates. This review aims at analyzing the outcomes of transcatheter valvular procedures in this subset of patients. A systematic
-
Percutaneous Suture-based Patent Foramen Ovale Closure: a state-of-the-art review Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-11-04 Francesco Cannata, Kamil Stankowski, Dario Donia, Stefano Figliozzi, Fabio Fazzari, Damiano Regazzoli, Bernhard Reimers, Renato Maria Bragato, Gianluca Pontone, Daniela Trabattoni, Antonio Colombo, Federico De Marco, Antonio Mangieri
Percutaneous closure of a patent foramen ovale (PFO), a common variation of interatrial septum anatomy, is a commonly performed procedure in the catheterization laboratory to reduce the risk of recurrent stroke in selected patients and to treat other PFO-related syndromes. In the last twenty years, disc-based devices have represented the armamentarium of the interventional cardiologist; recently, suture-based
-
The Optimal Time Restricted Eating Interventions for Blood Pressure, Weight, Fat Mass, Glucose, and Lipids: A Meta-analyses and Systematic Review Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-10-12 Xiaohua Liang, Jingyu Chen, Xizou An, Yanling Ren, Qin Liu, Lan Huang, Ping Zhang, Ping Qu, Jianxin Li
-
Gender and Race-Related Disparities in the Management of Ventricular Arrhythmias Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-10-12 Mason Yoder, Anthony Dils, Apurba Chakrabarti, Stefanie Driesenga, Abiola Alaka, Michael Ghannam, Frank Bogun, Jackson J. Liang
Modern studies have revealed gender and race-related disparities in the management and outcomes of cardiac arrhythmias, but few studies have focused on outcomes for ventricular arrhythmias (VAs) such as ventricular tachycardia (VT) or ventricular fibrillation (VF). The aim of this article is to review relevant studies and identify outcome differences in the management of VA among Black and female patients
-
-
Editorial Commentary for State-of-the-Art Cardiac Magnetic Resonance in Pulmonary Hypertension - An Update on Diagnosis, Risk Stratification and Treatment Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-09-14 Keyur Vora, Rohan Dharmakumar
Abstract not available
-
The evolution of prosthetic heart valves and related preventative antithrombotic therapy: different paths with divergent progression Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-09-10 Marco Picichè
Abstract not available
-
The long and winding road to follow dyslipidemia guidelines Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-09-09 Aldo Bonaventura
Abstract not available
-
Practical Solutions for Implementation of Blood Cholesterol Guidelines in Clinical Practice Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-08-25 Gregory Piazza, Nihar R. Desai, Usman Baber, Jason Exter, Bethany Kalich, Peter Monteleone
Underutilization of lipid-lowering therapy (LLT) and failure to attain guideline-recommended low-density lipoprotein cholesterol (LDL-C) goals are important quality gaps in cardiovascular risk optimization, especially among patients with atherosclerotic cardiovascular disease (ASCVD). Large database analyses demonstrate an unmet need for improved LDL-C measurement, and that nearly 75% of patients with
-
-
Clinical Translation of Vagus Nerve Stimulation in Cardiovascular Diseases: How Bright is the Light at the End of the Tunnel? Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-08-01 Richard L. Verrier
Abstract not available
-
Predicting Post-Operative Atrial Fibrillation (POAF): The Proof Is in the Fluid Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-07-26 Joshua A. Newman, Peter R. Kowey
Abstract not available
-
Vagus Nerve Stimulation for Cardiovascular Diseases: Is There Light at the End of the Tunnel? Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-07-26 Stefanos Zafeiropoulos, Umair Ahmed, Alexia Bikou, Ibrahim T. Mughrabi, Stavros Stavrakis, Stavros Zanos
Autonomic dysfunction and chronic inflammation contribute to the pathogenesis and progression of several cardiovascular diseases (CVD), such as heart failure with preserved ejection fraction, atherosclerotic CVD, pulmonary arterial hypertension, and atrial fibrillation. The vagus nerve provides parasympathetic innervation to the heart, vessels, and lungs, and is also implicated in the neural control
-
Mechanical valve thrombosis: current management and differences between guidelines Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-07-26 Adela Serban, Dana Gavan, Diana Pepine, Alexandra Dadarlat, Raluca Tomoaia, Stefan Mot, Alexandru Achim
All foreign bodies inserted in the circulatory system are thrombogenic and require temporary or lifelong antithrombotic therapies to prevent thrombosis. The adequate level of anticoagulation during the first few months determines the long-term durability, particularly for mechanical prostheses;2 however also for biological valves. Suboptimal anticoagulation is the most frequent source of mechanical
-
Regression and stabilization of atherogenic plaques. Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-07-24 Jairo Aldana-Bitar, Deepak L. Bhatt, Matthew J. Budoff
Atherosclerotic plaque assessment has become a crucial element in the examination of cardiovascular diseases. Plaque may exhibit progression and could become unstable if not treated, making plaque regression and stabilization among the most important goals of any cardiovascular intervention in cardiovascular medicine. In this review, we explore the current understanding of plaque regression and stabilization
-
Chronic kidney disease and aortic valve replacement: Let's filter the evidence! Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-07-10 Matheus Simonato, Danny Dvir, Michael G. Nanna
Abstract not available
-
-
The mundane and the profound of QT prolongation in the opioid abuse crisis Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-07-06 J. Kevin Donahue
Abstract not available
-
Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement in Chronic Kidney Disease: Meta-Analysis of Reconstructed Time-to-Event Data Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-05-09 Xander Jacquemyn, Jef Van den Eynde, Quinten Iwens, Janne Billiau, Habib Jabagi, Derek Serna-Gallegos, Danny Chu, Ibrahim Sultan, Michel Pompeu Sá
BACKGROUND Patients with advanced chronic kidney disease (CKD) are a challenging and understudied population. Specifically, the late outcomes following surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) in patients with CKD remains uncertain. OBJECTIVES To compare overall mortality risk in patients with moderate-to-severe CKD following TAVI versus SAVR. METHODS
-
Transcatheter aortic valve implantation in bicuspid aortic valve stenosis Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-05-06 Michel Pompeu Sá, Xander Jacquemyn, Ibrahim Sultan
Abstract not available
-
-
Screening for Aortic Stenosis in At Risk Older Patients – A New Paradigm in Valvular Heart Disease Care? Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-05-01 Onyedika J. Ilonze
Abstract not available
-
Surgical vs Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis: A Systematic Review and Meta-analysis Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-04-28 Jimmy JH. Kang, Nicholas M. Fialka, Ryaan EL-Andari, Abeline Watkins, Yongzhe Hong, Anoop Mathew, Sabin J. Bozso, Jeevan Nagendran
This systematic review and meta-analysis aim to provide a comprehensive analysis of the literature directly comparing the outcomes of surgical aortic valve replacement (SAVR) and TAVR in patients with BAV stenosis. Medline, PubMed, and Scopus were systematically searched for articles published between 2000-2023, 1,862 studies were screened, and 6 retrospective studies met the inclusion criteria. We
-
Rhythm Control in Atrial Fibrillation: How the Early Bird May Get the Worm Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-04-27 Alexander Turin, Eugene H Chung
Abstract not available
-
A Call to Consider an Aortic Stenosis Screening Program Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-04-25 Ju Young Bae, Arzhang Fallahi, Wayne Miller, Martin B. Leon, Theodore P. Abraham, Sripal Bangalore, David H. Hsi
Aortic stenosis (AS) is the most common age-related valvular condition with a prevalence of 13.1% in patients older than 75 years of age. Based on the severity of AS and symptoms, current guidelines recommend interval monitoring with transthoracic echocardiogram (TTE). However, no guidelines exist regarding screening asymptomatic persons for AS. Prevalence of AS is comparable to conditions such as
-
Benefits of early rhythm control of atrial fibrillation Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-04-11 L. Eckardt, J. Wolfes, G. Frommeyer
In contrast to current guidelines and earlier trials, recent studies demonstrated superiority of rhythm- over rate-control and challenged the strategy of "rate versus rhythm" therapy in patients with atrial fibrillation. These newer studies have started to shift the use of rhythm-control therapy from the symptom-driven therapy of current guidelines to a risk-reducing strategy aimed at restoring and
-
The Complex Interplay Between Periodontal and Cardiovascular Disease: The eyes to know the Soul, the Mouth to See the Heart. Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-04-06 Edgar Francisco Carrizales-Sepúlveda
Abstract not available
-
Opioids-Induced Inhibition of HERG Ion Channels and Sudden Cardiac Death, A Systematic Review of Current Literature Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-04-02 Adham El Sherbini, Kiera Liblik, Junsu Lee, Adrian Baranchuk, Shetuan Zhang, Mohammad El-Diasty
Background It is estimated that over 60 million individuals regularly use opioids globally, with opioid use disorder increasing substantially in the past decade. Several reports have linked sudden cardiac death, QTc prolongation, and other adverse cardiovascular outcomes with opioid use through their inhibitory effect on the human ether-a-go-go-related gene (HERG) ion channel. Therefore, understanding
-
-
Heart Rate and Rhythm in Cardiac Amyloidosis Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-03-26 Brett W. Sperry, Uttsav Sandesara, Jessica Kline
Abstract not available
-
Oral health as a modifiable risk factor for cardiovascular diseases Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-03-23 Serena Altamura, Rita Del Pinto, Davide Pietropaoli, Claudio Ferri
Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality worldwide with a high socioeconomic burden. Increasing evidence supports a convincing connection with increased cardiovascular risk of periodontal diseases (PD), a group of widespread, debilitating, and costly dysbiotic relapsing-remitting inflammatory diseases of the tissues supporting the teeth. Herein, we ensembled the
-
Robotic Applications for Intracardiac and Endovascular Procedures: Are We Ready for Robotic Takeover? Trends Cardiovasc. Med. (IF 9.3) Pub Date : 2023-03-20 Fengwei Zou, Luigi Di Biase
Abstract not available